Lubrizol Corporation, a US-based, provider of specialty chemicals has signed a Memorandum of Understanding (MoU) with Polyhose, a provider of fluid delivery systems, to build a medical tube manufacturing facility in Tamil Nadu, India.

The proposed facility is anticipated to begin construction in 2025 and is expected to begin operations in 2026. About 200 jobs are anticipated to be created by the facility, which will be situated in Kelambakkam, Chennai.

The MoU, which follows a long-standing partnership between the two organizations, was signed in the presence of Tamil Nadu’s Minister for Industries, Investment Promotions and Commerce Dr. T. R. B. Rajaa and the state’s Industry Secretary V Arun Roy. After the signing, Lubrizol also contacted Tamil Nadu’s Chief Secretary N. Muruganadam.

The new facility aims to increase Lubrizol’s local medical tubing volume fivefold. Lubrizol wants the site to facilitate access to life-saving medical tubing through local distribution in India and exports to international markets.

Rebecca Liebert, president and CEO, Lubrizol, said the facility will “reduce reliance on imports to service medical device need” in India while allowing the firm to expand into new markets.

She added that India was a “hub for Lubrizol’s innovation and growth”. She emphasised that the firm’s “ongoing investment highlights [their] dedication to local-for-local and local-for-global strategy in India.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The medical tubing will be manufactured using Lubrizol’s medical-grade thermoplastic polyurethanes (TPUs) and other thermoplastic polymers that provide biocompatibility.

In the past year alone, Lubrizol has invested over $350m in India. The firm opened its  Global Capabilities Center (GCC) in Pune in April. They also announced the purchase of land in Aurangabad to build its largest manufacturing facility in India and its second largest in the world.

Just one year ago, Lubrizol commissioned the first phase of a 100,000-ton CPVC resin plant in Vilayat, Gujarat, India, the world’s largest single-site CPVC resin production plant. In addition, Lubrizol is doubling its CPVC compound manufacturing capacity at its Dahej, Gujarat, site to meet growing needs in the piping sector.